Find Locations
For hours, walk-ins and appointments.Synonyms
- PTH Intact
Special Instructions
This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H, or coenzyme R). It is recommended to ask all patients who may be indicated for this test about biotin supplementation. Patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample.
Expected Turnaround Time
Within 1 day
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Related Documents
Specimen Requirements
Specimen
Plasma and serum
Volume
1.5 mL plasma and 1 mL serum
Minimum Volume
0.7 mL plasma and 0.5 mL serum
Container
Lavender-top (EDTA) tube and red-top tube or gel-barrier tube
Collection
Transfer separated plasma to a plastic transport tube clearly labeled as EDTA plasma and maintain refrigerated temperature. If red-top tube is used, transfer serum to a plastic transport tube clearly labeled as serum.
Storage Instructions
Serum: Room temperature
Plasma: Refrigerated
Stability Requirements
Temperature | Period |
|---|---|
Room temperature | Serum: 14 days |
Plasma: 2 days (stability determined by manufacturer or literature reference) | |
Refrigerated | Serum: 14 days |
Plasma: 3 days (stability determined by manufacturer or literature reference) | |
Frozen | Serum: 14 days |
Plasma: 6 months (stability determined by manufacturer or literature reference) | |
Freeze/thaw cycles | Serum: Stable x3 |
Plasma: Stable x1 (stability determined by manufacturer or literature reference) |
Causes for Rejection
Whole blood; plasma other than EDTA; hemolysis; room temperature serum sent for PTH intact
Test Details
Use
This test is used for differential diagnosis of hypercalcemia. PTH is an 84-amino acid peptide hormone that is responsible for the regulation of serum calcium levels within a narrow range.
PTH is secreted in response to decrease in serum calcium levels by increasing the renal reabsorption of calcium and lowering reabsorption of phosphorus. The measurement of PTH is a useful tool in the differential diagnosis and management of hypercalcemia. PTH assays can be of help in the diagnosis of tumors and hyperplasia of the parathyroid gland, as well as in localizing hyperfunctioning parathyroid tissue by assay of samples obtained via venous catheterization. The native or intact (1-84) PTH has a short half-life, measured in minutes, whereas the carboxy and midmolecule fragments, which are biologically inactive, have half-lives 10- to 20-fold higher. The high concentrations of biologically inactive fragments have interfered with use of C-terminal or midmolecule assays for evaluation of parathyroid function in patients with impaired renal function. Intact PTH assays provide a more accurate assessment of parathyroid patients including those with various renal diseases.
Methodology
Plasma: electrochemiluminescence immunoassay (ECLIA); serum: colorimetric
References
Brown RC, Aston JP, St John A, Woodhead JS. Comparison of poly- and monoclonal antibodies as labels in a two-site immunochemiluminometric assay for intact parathyroid hormone. J Immunol Methods. 1988 Apr 22; 109(1):139-144. 3356909
Endress DB, Villanueva R, Sharp CF Jr, Singer FR. Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: Performance in the differential diagnosis of hypercalcemia and hyperparathyroidism. Clin Chem. 1991 Feb; 37(2):162-168. 1993319
Kao PC, van Hearden J, Grant CS, Klee GG, Khosia S. Clinical performance of parathyroid hormone immunometric assays. Mayo Clin Proc. 1992 Jul; 67(7):637-645. 1434896
Nussbaum SR, Zahradnik RJ, Lavigne JR, et al. Highly sensitive two-site immunoradiometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 1987 Aug; 33(8):1364-1367. 3608153
LOINC® Map
| Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
|---|---|---|---|---|---|---|
| 054601 | Ca+PTH Intact | 24346-9 | 001016 | Calcium | mg/dL | 17861-6 |
| 054601 | Ca+PTH Intact | 24346-9 | 015610 | PTH, Intact | pg/mL | 2731-8 |
| 054601 | Ca+PTH Intact | 24346-9 | 004000 | Intact PTH | N/A |
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf